U.S. markets open in 4 hours 56 minutes
  • S&P Futures

    3,799.75
    -17.00 (-0.45%)
     
  • Dow Futures

    31,149.00
    -87.00 (-0.28%)
     
  • Nasdaq Futures

    12,604.75
    -77.00 (-0.61%)
     
  • Russell 2000 Futures

    2,194.50
    -11.30 (-0.51%)
     
  • Crude Oil

    60.93
    -0.35 (-0.57%)
     
  • Gold

    1,706.00
    -9.80 (-0.57%)
     
  • Silver

    25.80
    -0.59 (-2.22%)
     
  • EUR/USD

    1.2039
    -0.0028 (-0.23%)
     
  • 10-Yr Bond

    1.4700
    0.0000 (0.00%)
     
  • Vix

    26.93
    +2.83 (+11.74%)
     
  • GBP/USD

    1.3933
    -0.0020 (-0.14%)
     
  • USD/JPY

    107.2900
    +0.2880 (+0.27%)
     
  • BTC-USD

    48,785.05
    -1,887.43 (-3.72%)
     
  • CMC Crypto 200

    979.22
    -7.99 (-0.81%)
     
  • FTSE 100

    6,626.50
    -48.97 (-0.73%)
     
  • Nikkei 225

    28,930.11
    -628.99 (-2.13%)
     

Galapagos (GLPG) Surges: Stock Moves 8.8% Higher

  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

Galapagos NV GLPG was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company—as the stock is now down 29.3% in the past one-month time frame.

The company's Zacks Consensus Estimate for the current quarter has moved higher over the past few weeks, suggesting that more solid trading could be ahead for Tailored Brands. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Galapagos has a Zacks Rank #4 (Sell) while its Earnings ESP is positive. 

Galapagos NV Price

Galapagos NV Price
Galapagos NV Price

Galapagos NV price | Galapagos NV Quote

Investors interested in the Medical – Biomedical and Genetics industry may consider Emergent Biosolutions Inc EBS which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Emergent Biosolutions Inc. (EBS) : Free Stock Analysis Report
 
Galapagos NV (GLPG) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.